Gene-silencing activity mediated by siRNA has been demonstrated in mammalian cells; however, the mechanism of its regulation is not well understood. Since downregulation of a number of genes occurs during adenosine 3 0 ,5 0 -cyclic monophosphate (cAMP)-induced differentiation of neuroblastoma (NB) cells, it is possible that cAMP may play a role in regulating siRNA activity during differentiation. To study this, we utilized an NB cell line (NBP2-PN25) that expresses a short-lived green fluorescent protein (d2EGFP) under the CMV promoter. These cells were transfected with a retroviral plasmid that expresses U6 promoter-driven expression of siRNA targeted to d2EGFP and then were treated with cAMPelevating agents (200 lg/ml RO20-1724, an inhibitor of cyclic nucleotide phosphodiesterase, and 1 lg/ml prostaglandin A 1 , a stimulator of adenylate cyclase) for 2 or 24 h. The siRNA activity was measured by determining the level of intensity of d2EGFP protein by flow cytometry, and the level of d2EGFP mRNA by real-time PCR. The results showed that cAMP-elevating agents enhanced U6-driven siRNA activity directed towards d2EGFP in NB cells 24 h after treatment. One of the mechanisms of action of cAMP is mediated via phosphatidylinositol 3-kinase (PI3K) inhibition; therefore, we have investigated the effect of a PI3K inhibitor on siRNA activity. This study showed that inhibition of PI3K also enhanced U6-driven siRNA activity towards d2EGFP. cAMP-stimulating agents increased U6 transcript levels, perhaps suggesting that increased siRNA activity may in part be due to an increase in transcriptional activity. When NB cells were transfected with a synthetic siRNA directed to d2EGFP, both cAMP elevation and PI3K inhibition similarly enhanced siRNA activity. Sodium butyrate, which inhibits the growth of NB cells similar to the effect produced by cAMP, did not affect U6-driven siRNA activity towards d2EGFP. Protein kinase C (PKC) activation or inhibition also failed to affect siRNA activity in NB cells. This study also showed that cAMP elevation and PI3K inhibition increases U6-driven siRNA activity directed towards an endogenous gene, p53. Our data suggest a role for the cAMP pathway in affecting the efficacy of siRNA system during differentiation of NB cells.
Introduction
Gene-silencing system is a multi-component complex consisting of Dicer enzyme, which processes dsRNA into siRNA, and a multi-component nuclease, RNAinduced silencing complex (RISC), which is activated by incorporation of siRNA. Activated RISC guides siRNA to a specific mRNA sequence for degradation (Hannon, 2002; Pickford and Cogoni, 2003) . Micro RNAs (miRNA) are widely found in animals and plants. Although more than 200 miRNAs have been identified in mammalian cells, the target RNAs for most miRNAs remain mostly unknown (Elbashir et al., 2001; Tijsterman et al., 2002; Grewal and Moazed, 2003; Bartel, 2004) . In addition, the mechanism of regulation of the activity of siRNA in mammalian cells is not well understood. On the contrary, it has been suggested that mammalian cells lack the mechanisms that are found in worms and plants to amplify gene-silencing activities (Pickford and Cogoni, 2003) . It has also been reported that synthetic siRNA can be readily introduced into postmitotic primary neuron cultures and effectively reduced the expression of endogenous and transfected genes (Krichevsky and Kosik, 2002) . SiRNA-directed gene-silencing activity has also been demonstrated in human tumor cells in culture (Morris et al., 2004; Takei et al., 2004) . We have reported that over 95% of a murine neuroblastoma (NB) cell line can be terminally differentiated by an elevation of the intracellular level of adenosine 3 0 ,5 0 -cyclic monophosphate (cAMP) (Prasad, 1991; Hanson et al., 2003) . These differentiated NB cells may require reduced transcriptional activity in comparison to undifferentiated NB cells. Indeed, we have reported that the expression of several genes is downregulated in cAMP-induced differentiated NB cells (Yan et al., 2002) . Therefore, it is possible that one of the mechanisms of downregulation of gene expression during cAMP-induced differentiated NB cells may involve increased siRNA activity. In order to investigate this, we utilized NB cells that express a destabilized enhanced green fluorescence protein (d2EGFP) gene under the control of the CMV promoter (Nahreini et al., 2001a) . These NB cells were transiently transfected with retroviral plasmids encoding U6 promoter-driven expression of siRNA directed to d2EGFP and were treated 24 or 2 h later with cAMP-elevating agents (200 mg/ml RO20-1724, an inhibitor of cyclic nucleotide phosphodiesterase activity, and 1 mg/ml prostaglandin A 1 (PGA 1 ), a stimulator of adenylate cyclase). siRNA activity was determined by measuring the intensity of d2EGFP protein by flow cytometry, and d2EGFP mRNA by real-time PCR. We also investigated the effect of cAMP on U-driven expression of siRNA directed towards p53 gene. We now report that treatment of NB cells with cAMP-stimulating agents increase the activity of siRNA directed towards d2EGFP mRNA or towards p53 mRNA during differentiation of NB cells.
Results
Effect of cAMP-elevating agents or a phosphatidylinositol 3-kinase (PI3K) inhibitor on U6-driven siRNA activity directed to d2EGFP in NB cells
To study the effect of elevated cAMP level on siRNA activity, NB cells (NBP2-PN25) overexpressing shortlived green fluorescence protein (d2EGFP) gene were transfected with a vector encoding U6 promoter-driven expression of siRNA directed to d2EGFP mRNA (Figure 1) , and cAMP-elevating agents (RO20-1724 and PGA 1 ) or a PI3K inhibitor were added 24 h later for a period of 2 and 24 h. Since one of the mechanisms of action of cAMP in some mammalian cells is mediated via PI3K inhibition (Castell et al., 2003; Khaled et al., 2003; Lee and Kay, 2003; Poser et al., 2003) , the effect of a PI3K inhibitor on siRNA activity was investigated. The gene-silencing activity of siRNA was measured by determining the level of d2EGFP mRNA by real time PCR. Figure 2 showed that the expression of d2EGFP mRNA decreased in cAMP-or a PI3K inhibitor-treated NB cells 24 h after treatment. The reduction in expression of this gene was evident as early as 2 h after treatment with cAMP-elevating agents (data not shown). It should be noted that treatment of NB cells (PN116) with cAMP-elevating agents increased the levels of d2EGFP mRNA, presumably by activating the CMV promoter (Nahreini et al., 2001a ). An inhibitor of PI3K activity appeared to be more effective than cAMP elevation in reducing the expression of this transfected gene.
The efficacy of siRNA activity was also determined by measuring the flow cytometry profile of d2EGFP protein ( Figure 3 Figure 1 Schematic representation of retroviral vectors used to study siRNA activity in NBP2-PN25 cells. For details of vector construction, see Materials and Methods section. LTR -longterminal repeat of murine leukemia virus; Neo r -neomycin resistance gene; U6 -U6 promoter; MCS -multiple cloning site; siRNAaGFP -short hairpin RNA sequence directed to d2EGFP. A vector encoding U6 promoter-driven expression of siRNA directed to d2EGFP mRNA is referred to as PN132, whereas a vector without siRNA is referred to as PN116. PN193 refers to a vector coding U6 promoter-driven siRNA directed to p53mRN. PN172 refers to a vector coding U6 promoter to study its transcriptional activity after treatment with cAMP or a PI3K inhibitor 
Effect of cAMP-stimulating agents on U6 transcript
In order to determine if cAMP-induced enhancement of siRNA activity is related to the production of more siRNA, a vector encoded with U6 was constructed (PN172) (Figure 1 ). NB cells were transfected with this vector and the level of U6 transcript was determined 24 h after treatment with cAMP-elevating agents. The results revealed that an elevation of cAMP level in NB cells increased the U6 transcripts by 2.4970.27-fold.
Effect of cAMP-stimulating agents or a PI3K inhibitor on synthetic siRNA activity directed to d2EGFP in NB cells
In order to ascertain whether elevation of cAMP levels or inhibition of PI3K activity can increase the efficacy of synthetic siRNA in reducing the expression of d2EGFP, we transfected NBP2-PN25 cells with synthetic siRNA and then treated the cells with cAMP-elevating agents or a PI3K inhibitor 24 h later for a period of 24 h. The results showed that both cAMP elevation and PI3K inhibition enhanced the activity of synthetic siRNA as evidenced by reduced expression of d2EGFP mRNA Effect of sodium butyrate on U6-driven siRNA activity directed to d2EGFP in NB cells
Like cAMP, sodium butyrate also inhibits growth of NB cells in culture (Prasad and Sinha, 1976; Prasad, 1980) . In order to determine whether the cAMP-induced increase in siRNA activity was related to growth inhibition rather than to cAMP elevation, cells were transfected with a vector encoding U6 promoter-driven expression of siRNA directed to d2EGFP mRNA, and sodium butyrate (0.25 mM) was added 24 h later for a period of 24 h. The activity of siRNA was determined by measuring the d2EHFP protein level by flow cytometry profile. The results showed that sodium butyrate treatment did not alter the cytometric profile of protein in transfected cells in comparison to untreated transfected NB cells (data not shown).
Effect of protein kinase C (PKC) activation or inhibition on U6-driven siRNA activity directed to d2EGFP in NB cells
In order to determine whether activation or inhibition of PKC can increase the efficacy of siRNA in NB cells, we transfected NBP2-PN25 cell with a vector coding siRNA directed toward d2EGFP mRNA and added Effect of cAMP-stimulating agents or a PI3K inhibitor on U6-driven siRNA activity directed to p53 gene in NB cells
In order to ascertain that cAMP also enhances siRNA activity directed to an endogenous gene, a vector encoding siRNA directed to p53 mRNA was constructed (PN193). Cells were transfected with this vector and cAMP-stimulating agents or a PI3K inhibitor was added 24 h later for a period of 24 h. The level of p53 mRNA was analysed by real-time PCR. The results showed that an elevation of cAMP or a PI3K inhibitor reduced the expression of p53 mRNA in vector controltransfected cells; however, each of them further decreased the expression of p53 mRNA in cells transfected with a vector coding for U6-driven siRNA directed towards p53 gene ( Figure 5 ).
Discussion
The present study suggests that an elevation of cAMP level increases the activity of siRNA as evidenced by reduced expression of transfected d2EGFP at both mRNA and protein levels in NB cells 24 h after treatment. This effect of cAMP is observed as early as 2 h after treatment. Sodium butyrate inhibits the growth of NB cells similar to growth inhibition induced by cAMP elevation (Prasad and Sinha, 1976; Prasad, 1980) ; however, it does not alter siRNA activity, suggesting that cAMP-induced increase in siRNA activity is not related to growth inhibition. Furthermore, a PKC activation or inhibition also does not enhance the activity of siRNA in NB cells. These data suggest that cAMP-induced enhancement of siRNA activity may be the unique effect of cAMP in NB cells. This study also shows that cAMP enhances the expression of U6 promoter as well as the activity of synthetic siRNA, suggesting that the mechanisms of action of cAMPinduced enhancement of siRNA activity may involve steps other than enhancement of transcriptional activity. Inhibition of PI3K or an elevation of cAMP may produce similar or opposite effects on mammalian cells, depending upon the assay parameters and cell type (Castell et al., 2003; Khaled et al., 2003; Lee and Kay, 2003; Poser et al., 2003) . In this study, PI3K inhibition increased siRNA activity in NB cells similar to that produced by cAMP elevation. PI3K inhibition also enhances the activity of synthetic siRNA directed to d2EGFP by a similar extent. This suggests that one of the mechanisms of action of cAMP in enhancing siRNA activity may involve PI3K inhibition.
cAMP-induced increase in siRNA activity in NB cells may be due to an increase in the stability of siRNA, an increase in transport of siRNA, an increase in the activity of U6 promoter of siRNA, or an increase in the activity or level of RISC. Since cAMP-elevating agents increase U6 promoter activity, it is likely that one of the mechanisms of action of cAMP may involve stimulation of U6 promoter activity. The fact that cAMP also increases the activity of synthetic siRNA suggests that cAMP may mediate its action by mechanisms other than the stimulation of U6 promoter. A recent study has revealed that siRNA-directed gene-silencing activity towards 1 alpha (EF1A) promoter-driven GFP and of endogenous gene EF1A is associated with DNA methylation of the target sequence. This process requires either active transport of siRNA into the nucleus or permeabilization of the nuclear envelop by lentiviral transduction (Morris et al., 2004) .
This study also reports that cAMP-stimulating agents and a PI3K inhibitor also enhance siRNA activity directed to p53 mRNA. This result, together with the previous data, suggests that cAMP elevated the activity of siRNA directed towards both transfected and endogenous genes.
We have previously reported that an elevation of intracellular levels of cAMP in NB cells induces terminal differentiation over 95% of cell population (Prasad, 1991; Hanson et al., 2003) . We have also shown that downregulation of many genes occurs during cAMPinduced differentiation of NB cells (Yan et al., 2002) . Therefore, we propose that one of the mechanisms of action of cAMP-induced downregulation of certain Figure 5 Effects of cAMP elevation or PI3K inhibition on U6-driven siRNA activity directed toward p53 mRNA in NB cells. Cells were transfected with a vector encoding U6-driven siRNA directed toward p53 mRNA (PN193) and treated with cAMPelevating agents or a PI3K inhibitor 24 h later for a period of 24 h. Real-time PCR was performed on cDNA generated from mRNA isolated from NBP2-PN25 as described in the Materials and methods section. The results showed a marked reduction in the level of p53 mRNA after treatment with cAMP or an inhibitor of PI3K in comparison to vector control cells. Error bars indicate % variance among Cp values for each sample. * indicates samples in which Po0.001 when compared to control cAMP enhances siRNA activity in neuroblastoma cells AJ Hanson et al genes that is necessary for initiating and promoting differentiation in NB cells may be mediated via endogenously generated siRNAs. The present observations on cAMP-induced increase in siRNA activity may be of developmental and evolutionary significance, since cAMP plays a role in regulating differentiation from prokaryotic to eukaryotic cells.
Materials and methods

Cell culture
A murine NB cell line (NBP2-PN25), which expresses destabilized enhanced green fluorescent protein, was used for this study (Nahreini et al., 2001a) . NB cells were grown in F12 medium (Gibco Products, Invitrogen Corp., Grand Island, NY, USA) containing 3% Tet System Approved fetal bovine serum (Clontech, Palo Alto, CA, USA), 100 U/ml penicillin, and 100 mg/ml streptomycin (Gibco Products, Invitrogen Corp.).
Solution preparation
PGA 1 (Sigma, St Louis, MO, USA), a stimulator of adenylate cyclase, and 4-3-butoxy-4-methoxybenzyl-2-imidazolidinone (RO20-1724), an inhibitor of cyclic nucleotide phosphodiesterase, (a gift from Hoffman La Roche, Nutley, NJ, USA) were dissolved in ethanol. PGA 1 solutions were protected from light and were stored at À201C. The solution of RO20-1724 was stored at room temperature. LY294004, an inhibitor of PI3K activity (Sigma), TPA (Calbiochem), and GF109203X (Calbiochem) were dissolved in DMSO and stored at À201C, protected from light.
Construction of siRNA vectors
Vector PN-116 was constructed by subcloning the PvuII fragment of pBS/U6 plasmid (a gift from Dr Yang Shi, Harvard Medical School), containing the U6-driven expression cassette, into the HpaI/BamHI sites in the PN-2 retroviral vector after blunt-ending the DNA fragments with Klenow. PN-2 is the same as PN-1 (Nahreini et al., 2001b) , except that it lacks the cytomegalovirus (CMV) immediate early promoter. Vectors PN132 and PN193 were constructed by annealing 1 mg of the forward and reverse strands of custom-synthesized oligonucleotides (Invitrogen) for d2EGFP-specific (5 0 -ATCGA CTTCAAGGAGGACGGCAACATCAAGTTCTGAGATGT TGCC GTCCTCCTTGAAGTCGATTTTTT-3 0 and 5 0 -AGC TAAAAAATCGACTTCAAGGAGGACGGCAACATCTCA GAACTTGATGTTGCCGTCCTCCTTGAAGTCGATGG CC-3 0 ) or p53-specific siRNA (5 0 -TCGAAATAAGCTATT CTGCC AGCTGGCGAAGACAAGTTCTGAGTCTTCGC CAGCTGGCAGAATAGCTTATTTTT-3 0 AND 5 0 -AGCTAA AAATAAGCTATTCTGCCAGCTGGCGAAGACTCAGAA CTTGTCTTCGCCAGCTGGCAGAATAGCTTATT-3 0 ), in 1 Â annealing buffer (10 mM Tris-HCl, pH 8.5, 150 mM NaCl, 15 mM sodium acetate) in a total volume of 20 ml. The oligonucleotides were heated at 951C for 10 min and gradually cooled to room temperature. The annealed oligonucleotides, containing ApaI/HindIII cohesive ends, were subcloned into the MCS of PN-116 and the resulting vector was designated as PN-132. To construct PN-172, a 100 nt-long nonpalindromic sequence of the d2EGFP coding region (5 0 -TCGAACGTAA ACGG CCACAAGTTCAGCGTGTC CGGCGAGGGCGA GGGCGATGCCACCTACG GCAA GCTGACCCT GAAC ACATGAAGCAGCACGACTTTTT-3 0 ) was cloned into the MCS of the U6 promoter. PN-172 was constructed to examine the transcriptional activity of the U6 promoter in the presence or absence of cAMP-inducing agents.
Transient transfection with siRNA vectors Cells (7.5 Â 10 5 ) were plated in a 6 cm tissue culture dish containing media with serum but without penicillin or streptomycin. Cells were transfected with Lipofectamine 2000t (Invitrogen Life Technologies, Inc., Carlsbad, CA, USA) 24 h after plating, using 30 ml of Lipofectamine 2000t and 6 mg of DNA. The cells were placed at 371C, 5% CO 2 for 24 h. The plates were washed once with media, and the cells were analysed by flow cytometry 2 or 24 h post transfection.
Transient transfection with synthetic dsRNA
Cells were plated and transfected as described above using 10 ml Lipofectamine 2000 TM and 20 pmol synthetic doublestranded RNA (Qiagen, Chatworth, CA, USA).
Real-time PCR for d2EGFP expression
Real-time RT-PCR was performed using total RNA extracted from transfected cells using the RNeasy TM Mini Kit (Qiagen, Chatworth, CA, USA). cDNA was synthesized using the SuperScript First-Strand Synthesis System and oligo(dT) [12] [13] [14] [15] [16] [17] [18] primers (Invitrogen Life Technologies, Carlsbad, CA, USA). Real-time PCR was carried out using the Lightcycler FastStart DNA Master SYBR Green I kit (Roche Diagnostics, Indianapolis, IN, USA) and the following primer sets: d2EGFP 5 0 -ACGTAAACGGCCACAAGTTC-3 0 and 5 0 -AA GTCGTGCTGCTTCATGTG-3 0 ; S29 5 0 -AAGGCAAGATG GGTCACCAGCAGCTCTA-3 0 and 5 0 -TACAAAGACTAG CATGATCGGTTCCACT-3 0 . Reactions were run in triplicate, and three independent experiments were run for each sample. Relative quantification of d2EGFP expression was determined by comparison of the amount of d2EGFP transcript to a housekeeping gene (S29) using Relative Expression Software (REST & ) (Pfaffl et al., 2002) .
Real-time PCR for U6 transcripts
Low molecular weight (LMW) RNA was isolated from NBP2-PN25 cells 48 h after transfection with vector PN172. RNA samples were treated with 2 U Turbo DNase (Ambion Inc., Austin, TX, USA) at 371C for 30 min to remove any contaminating genomic DNA. LMW RNA (1-5 mg) from cells was reverse-transcribed using the SuperScript First-Strand Synthesis System and random hexamer primers (Invitrogen Life Technologies, Carlsbad, CA, USA). Real-time PCR reactions were carried out in a LightCycler real-time PCR machine (Roche Diagnostics Corporation) using the following primer set: 5 0 -ACGTAAACGGCCACAAGTTC-3 0 and 5 0 -AAGTCGTGCTGCTTCATGTG-3 0 . PCR reactions were carried out in duplicate using diluted cDNA (1 : 5) and LightCycler FastStart DNA Master SYBR Green I reaction mix (contains Taq DNA polymerase, dNTPs, MgCl 2 , and SYBR Green I dye; Roche Diagnostics Corporation). A melting curve analysis was performed for each reaction to ensure the specificity of the reaction. Absolute quantification of U6 transcript was determined using a standard curve that was generated from serial dilutions of the annealed oligo used to construct vector PN172. This oligo is identical in sequence to the transcript generated from the U6 promoter of PN172.
Flow-cytometric analysis of d2EGFP expression
Cells were plated and transfected as described above. After treatment with various agents, cells were harvested, rinsed in growth medium, and resuspended in Hank's balanced salt solution for flow cytometry. All samples were analysed in the presence of 2 mg/ml propidium iodide using a Coulter EPICSt XL-MCL model flow cytometer at the UCHSC Flow Cytometry Core Facility. Each experiment was repeated at least three times, and a representative figure is provided.
Abbreviations NB, neuroblastoma; cAMP, adenosine 3 0 ,5 0 -cyclic monophosphate; PGA 1 , prostaglandin A 1 ; RO20-1724, 4-3-butoxy-4-methoxybenzyl-2-imidazolidinone; d2EGFP, destabilized enhanced green fluorescent protein; PI3K, phosphatidylinositol 3-kinase
